NOVARTIND

Pharmaceuticals

Novartis India Limited.

NSE: NOVARTINDBSE: 500672ISIN: INE234A01025
₹672.25
-17.10 · -2.48%
As of 25 Oct 2023
Open
₹691.05
High
₹698.20
Low
₹668.35
Prev Close
₹689.35
52W High
₹909.00
52W Low
₹537.00
Volume
11.8 K
Mkt Cap
₹5,995 Cr
Fundamentals
Valuation & profitability
Market Cap
₹5,995 Cr
P/E Ratio
—
EPS (TTM)
₹41.86
Book Value
—
Dividend Yield
—
ROCE
—
ROE
—
Sales Growth
—
Face Value
—
Key highlights
Auto-generated from live data
  • NOVARTIND is trading below all of its key moving averages (10/20/50/100/200-DMA) — a bearish technical setup.
  • At ₹672.25 it sits about 36% of the way up its 52-week range (₹537.00–₹909.00).
  • Market capitalisation stands at ₹5,995 Cr.
Price chart
Daily candles + volume · SMA 20 / 50 / 200 · stored OHLC
Shareholding pattern

Shareholding data syncs daily.

Moving averages
Simple moving averages vs current price
0/5 above · Bearish
SMA 10-Day
₹1,846.63Below
SMA 20-Day
₹1,676.99Below
SMA 50-Day
₹1,623.87Below
SMA 100-Day
₹1,453.82Below
SMA 200-Day
₹1,108.10Below
Price ranges
Where the price sits in each window
10-Day range₹672.25
₹1,480.00₹2,588.80
20-Day range₹672.25
₹1,402.00₹2,588.80
50-Day range₹672.25
₹1,402.00₹2,588.80
200-Day range₹672.25
₹668.35₹2,588.80
YTD range₹672.25
₹950.00₹2,588.80
52-Week range₹672.25
₹537.00₹2,588.80
Technical signals
Unfilled gaps acting as support / resistance
Unfilled Gap Up On 10 Sep, 2026 : 2232.10 ~ 2186.40SUPPORT
Unfilled Gap Up On 11 May, 2023 : 660.05 ~ 658.25SUPPORT
Annual financials
Revenue, profit & EPS by financial year
YearRevenueNet ProfitEPSNPM
Mar 2023₹379 Cr₹103 Cr₹41.8627.18%
Mar 2022₹400 Cr₹-4.00 Cr₹-1.51-1%
Mar 2021₹381 Cr₹21 Cr₹8.465.51%
Mar 2021₹381 Cr₹21 Cr₹8.465.51%
Mar 2020₹438 Cr₹10 Cr₹4.082.28%
Mar 2020₹438 Cr₹10 Cr₹4.082.28%
Mar 2019₹491 Cr₹52 Cr₹20.9710.59%
Mar 2018₹564 Cr₹78 Cr₹31.7413.83%
Mar 2017₹656 Cr₹57 Cr₹20.338.69%
Mar 2016₹690 Cr₹198 Cr₹62.0428.7%
Mar 2015₹870 Cr₹79 Cr₹24.759.08%
Mar 2014₹859 Cr₹99 Cr₹30.8311.53%
Peer comparison
Other companies in Pharmaceuticals
CompanyP/EBook ValueSales Growth
SUNPHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD.
39.1₹98.3310.1%
MARKSANS
MARKSANS PHARMA LTD.
23.8₹11.855.8%
MOREPENLAB
MOREPEN LABORATORIES LTD.
20.81₹6.4316.6%
NEULANDLAB
NEULAND LABORATORIES LTD.
23.48₹542.169.35%
GUFICBIO
Gufic BioSciences Ltd.
24.16₹10.8520.41%
DIVISLAB
DIVI'S LABORATORIES LTD.
41.01₹266.779.47%
DRREDDY
DR.REDDY'S LABORATORIES LTD.
19.73₹852.691.07%
RPGLIFE
RPG LIFE SCIENCES LTD.
17.14₹105.025.73%
GLAND
Gland Pharma Ltd
53.6₹242.00—
ZYDUSLIFE
Zydus Lifesciences Ltd
8.23₹166.005%
SMSPHARMA
SMS PHARMACEUTICALS LTD.
9.58₹42.07-8.73%
CIPLA
CIPLA LTD.
15.36₹209.710.7%
Dividend history
Per share, by ex-date
Ex-Date: 20 Jul 2023₹37.50
Ex-Date: 20 Jul 2023₹10.00
Ex-Date: 20 Jul 2022₹10.00
Ex-Date: 17 Aug 2021₹10.00
Ex-Date: 29 Jul 2020₹10.00
Ex-Date: 31 Jul 2019₹10.00
Ex-Date: 18 Jul 2018₹10.00
Ex-Date: 19 Jul 2017₹10.00
Ex-Date: 21 Jul 2016₹10.00
Ex-Date: 14 Jul 2015₹10.00
Ex-Date: 16 Jul 2014₹10.00
Ex-Date: 16 Jul 2013₹10.00
Bulk & block deals
Recent large transactions
DateClientTypeQtyPrice
16 Aug 2012IDFC SMALL AND MIDCAP EQUITY SME FUNDSALE2,20,217₹670.02
29 Aug 2007ICICI PRUDENTIAL ASSET MANAGEMENT CO.LTD.SALE9,23,800₹269.02
29 Aug 2007RELIANCE CAPITAL TRUSTEE CO.LTD.PURCHASE9,18,831₹269.00
23 Oct 2006PRUDENTIAL ICICI AMC LTDPURCHASE8,77,000₹435.00
23 Oct 2006T.ROWE PRICE INTERNATIONASALE8,77,221₹435.00
09 Jun 2006ICICI BANK LTD TREASURYSALE2,09,730₹422.00
09 Jun 2006TEMPLETON MUTUAL FUND ACPURCHASE2,09,440₹422.00
17 Feb 2006BIRLA SUNLIFE MUTUAL FUNDSALE4,36,221₹594.87
17 Feb 2006T ROWE PRICE INTERNATIONAPURCHASE4,39,221₹594.93
14 Feb 2006BIRLA SUNLIFE MUTUAL FUNDSALE3,41,517₹592.00
14 Feb 2006T ROWE PRICE INTERNATIONAPURCHASE3,43,000₹592.00
20 Dec 2005MORGAN STANLEYSALE3,00,000₹532.01

Fundamentals, financials & technicals sourced from niftytrader.in, cached and refreshed periodically.